ERIC EVANS

CHIEF FINANCIAL OFFICER

Eric has over thirty years of industry experience and a proven track record of leadership in building successful, high-growth companies in partnership with private equity firms, which have resulted in significant value creation for shareholders. He most recently served as CFO for TriPharm Services, which was acquired by Alcami in January 2020. Before TriPharm, he was CFO of Avista Pharma Solutions, where he played a key role in the expansion and sale of the company. Before Avista, he was CFO of Mayne Pharma US, a publicly-traded company operating in the generic, brand, and CDMO pharmaceutical industries, and, at private-equity backed AAIpharma Services, where he supported a successful expansion strategy. Other prior pharmaceutical leadership roles include CFO of Patheon Inc, a publicly-traded and private equity-backed CDMO at the time, and various senior finance roles with Novartis, including CFO of Sandoz Pharmaceuticals, Vice President and Controller of Novartis Pharmaceuticals and Vice President Finance of Novartis Pharmaceuticals.

KEN DOMAGALSKI

EXECUTIVE VICE PRESIDENT OF DRUG PRODUCT OPERATIONS

Ken joined Alcami in March of 2020 as the Executive Vice President of Drug Product Operations overseeing all drug product manufacturing facilities for Alcami. Ken has over 35 years in the pharmaceutical industry, of which 20 years were with Teva Parenteral Medicines and Gensia Sicor. Before Alcami, Ken served in ever-increasing responsibilities for Avista Pharma, including Chief Operations Officer and Active President of the early-stage business group encompassing 5 locations for Cambrex. Ken has served in various executive roles, including Vice President of Quality, Vice President of Operations, and Vice President of Process Engineering & Validation. He has led global organizations with hands-on experience, including validation of systems, equipment, cleaning, product, and processes in support of facility startups and new product introductions. During his tenure at Teva Parenteral Medicines, Ken led and provided significant direction in the build-out of a dedicated high potency facility, a facility for sterile suspensions as well as a facility for the manufacture of sterile emulsions. Ken also led automation efforts for the quality support systems as part of the facility and system design and enhancements. Ken has led numerous successful FDA, EMEA, MCA, and other international cGMP inspections. Ken holds a B.S. in Biology/Life Sciences from Niagara University.

LOUISE HALL, PMP

VICE PRESIDENT OF product development & TECHNOLOGY TRANSFER

Louise brings over 25 years of industry experience with a successful track record of driving results in drug development and manufacturing operations. Before joining Alcami, she was Vice President of Global Program Management and KBI Biopharma where she led a global team supporting the client interface for biologics drug substance development programs. Prior to that, Louise was the VP, CMC and Program Management at Locus Biosciences, where she led their strategic initiative to in-source GMP manufacturing supporting Pre-Clinical and Phase I clinical trials and established CMC Department focused on developing drug substance and drug product processes for revolutionary bacteriophage technology. In over 14 years with Patheon, Louise held various roles of increasing responsibility in Pharmaceutical Development Services and Project Management. Louise has a Bachelor of Science in Microbiology from the University of Waterloo and a Project Management Professional (PMP) certification from the Project Management Institute.

SALLY LANGA

SENIOR VICE PRESIDENT OF commercial operations

Joining Alcami in April of 2020, Sally is the Senior Vice President of Commercial Operations and is responsible for leading the Business Development team. Before Alcami, she was the Head of US Sales at Nanoform. Prior to this, she held senior leadership roles at Catalent as VP Global Development and Analytical Services, VP of Sales & Marketing at Halo Pharma, and over 25 years at Patheon. Sally brings significant experience in client-facing leadership roles in the contract service industry with a track record of creating technically capable and high-performing sales teams.

JACQUE URIBE 

VICE PRESIDENT OF QUALITY OPERATIONS

Jacque joined Alcami in January of 2020 as the Vice President of Quality Operations. Before joining Alcami, she was the Vice President of Quality at TriPharm Services and was responsible for all Quality and Compliance aspects of the company’s parenteral manufacturing operation and related testing. Before this, she used her depth of industry experience as a consultant for private equity firms.  Prior to this, she oversaw the Quality and Compliance of externally manufactured Commercial sterile products for Gilead Sciences, which encompassed aseptic processing, blow-fill-seal, and medical device operations, which totaled sixteen sites globally. Before Gilead, she was the Site Head of quality for the AAIPharma aseptic manufacturing facility located in Charleston, SC. Jacque holds a Bachelor of Science degree in Biology from the University of South Carolina.

BRIAN DILLION

VICE PRESIDENT OF REGULATORY AFFAIRS / QUALITY ASSURANCE

Brian returns to Alcami as our Vice President of Regulatory Affairs and Quality Assurance after spending two years leading quality assurance, regulatory, and compliance teams at Noramco. He brings over 30 years of industry experience and a proven track record of success in upholding the world’s highest standards in sterile product manufacturing, solid oral dosage manufacturing, and API manufacturing. Brian's depth of experience includes oversight of Laboratory Quality, Manufacturing Quality, Regulatory and Compliance, Business Quality, generic product development programs, and implementation and management of Commercial Product Quality Systems. Brian was employed by AAI Pharma/Alcami for 24 years and has been involved in the successful management of over 35 regulatory inspections. Brian holds a Bachelor of Science degree in Chemistry from Carson-Newman College and a Master's degree in Business Administration from the University of North Carolina Wilmington.

DAWN DE LOS SANTOS

VICE PRESIDENT OF HUMAN RESOURCES

Dawn has a breadth of HR expertise across 20 years that encompasses several industries, large and small companies, and both US and international responsibilities. Her prior experience includes eight years in the Biosciences Division of Thermo Fisher Scientific and five years at Pentair. Dawn has a track record of successfully delivering results across all aspects of HR, including talent management, leadership development, employee engagement, and cultural transformations. She is a champion of open and honest dialogue and is passionate about connecting with employees, creating positive cultures, and supporting strategic initiatives that drive growth. Dawn has her BS in Management with an emphasis in Human Resources from Northern Illinois University and an MBA from Northwestern University – Kellogg School of Management.

KEN MORGAN

VICE PRESIDENT & controller

Ken has over twenty years of experience in the pharmaceutical sector with considerable experience in finance, mergers, acquisitions, and information system implementations. Before joining Alcami, he was the Vice President and Controller of TriPharm Services, a parenteral manufacturing business acquired by Alcami. Before this, he spent twenty-two years at AAIPharma/Alcami in numerous financial leadership roles, including Vice President Financial shared services, Director of Finance, Asst. Treasurer, Financial Systems Manager, and Accounting Manager. Prior to the pharmaceutical industry, he served in roles as Plant Controller, Manager of Business Analysis, Internal Quality Auditor for ISO certification, and Cost Accountant in the pulp and paper industry. Ken has a BS in Accountancy from the University of North Carolina at Wilmington. 

BOB NEVRUZ

VICE PRESIDENT OF GLOBAL ENGINEERING

Bob joined Alcami in May of 2014 as the Senior Director of Engineering and Facilities and is now the Vice President of Global Engineering. Before joining Alcami, he was the Director of Engineering and Site Services at Catalent Pharma Solutions. Bob has nearly 30 years of industry experience and has held various leadership roles at Pfizer and GE Healthcare. Bob holds a Bachelor of Science degree in Chemical Engineering from North Carolina State University and a Master Certificate in Project Management from the Wisconsin School of Business.  

ERIC EVANS

CHIEF FINANCIAL OFFICER

Eric has over thirty years of industry experience and a proven track record of leadership in building successful, high-growth companies in partnership with private equity firms, which have resulted in significant value creation for shareholders. He most recently served as CFO for TriPharm Services, which was acquired by Alcami in January 2020. Before TriPharm, he was CFO of Avista Pharma Solutions, where he played a key role in the expansion and sale of the company. Before Avista, he was CFO of Mayne Pharma US, a publicly-traded company operating in the generic, brand, and CDMO pharmaceutical industries, and, at private-equity backed AAIpharma Services, where he supported a successful expansion strategy. Other prior pharmaceutical leadership roles include CFO of Patheon Inc, a publicly-traded and private equity-backed CDMO at the time, and various senior finance roles with Novartis, including CFO of Sandoz Pharmaceuticals, Vice President and Controller of Novartis Pharmaceuticals and Vice President Finance of Novartis Pharmaceuticals.

KEN DOMAGALSKI

EXECUTIVE VICE PRESIDENT OF DRUG PRODUCT OPERATIONS

Ken joined Alcami in March of 2020 as the Executive Vice President of Drug Product Operations overseeing all drug product manufacturing facilities for Alcami. Ken has over 35 years in the pharmaceutical industry, of which 20 years were with Teva Parenteral Medicines and Gensia Sicor. Before Alcami, Ken served in ever-increasing responsibilities for Avista Pharma, including Chief Operations Officer and Active President of the early-stage business group encompassing 5 locations for Cambrex. Ken has served in various executive roles, including Vice President of Quality, Vice President of Operations, and Vice President of Process Engineering & Validation. He has led global organizations with hands-on experience, including validation of systems, equipment, cleaning, product, and processes in support of facility startups and new product introductions. During his tenure at Teva Parenteral Medicines, Ken led and provided significant direction in the build-out of a dedicated high potency facility, a facility for sterile suspensions as well as a facility for the manufacture of sterile emulsions. Ken also led automation efforts for the quality support systems as part of the facility and system design and enhancements. Ken has led numerous successful FDA, EMEA, MCA, and other international cGMP inspections. Ken holds a B.S. in Biology/Life Sciences from Niagara University.

LOUISE HALL, PMP

VICE PRESIDENT OF product development & TECHNOLOGY TRANSFER

Louise brings over 25 years of industry experience with a successful track record of driving results in drug development and manufacturing operations. Before joining Alcami, she was Vice President of Global Program Management and KBI Biopharma where she led a global team supporting the client interface for biologics drug substance development programs. Prior to that, Louise was the VP, CMC and Program Management at Locus Biosciences, where she led their strategic initiative to in-source GMP manufacturing supporting Pre-Clinical and Phase I clinical trials and established CMC Department focused on developing drug substance and drug product processes for revolutionary bacteriophage technology. In over 14 years with Patheon, Louise held various roles of increasing responsibility in Pharmaceutical Development Services and Project Management. Louise has a Bachelor of Science in Microbiology from the University of Waterloo and a Project Management Professional (PMP) certification from the Project Management Institute.